501 results on '"Delacourte, André"'
Search Results
2. The natural and molecular history of Alzheimer’s disease: Tau is part of the story
3. Neurodegenerative Diseases : Tau Proteins in Neurodegenerative Diseases Other Than AD
4. O-GlcNAc Glycosylation and Neurological Disorders
5. The Molecular Parameters of Tau Pathology : Tau as a killer and a witness
6. The Orphan G Protein-Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons
7. Loss of microRNA Cluster miR-29a/b-1 in Sporadic Alzheimer's Disease Correlates with Increased BACE1/β-Secretase Expression
8. Involvement of β-Site APP Cleaving Enzyme 1 (BACE1) in Amyloid Precursor Protein-Mediated Enhancement of Memory and Activity-Dependent Synaptic Plasticity
9. Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease
10. Revising the definition of Alzheimer's disease: a new lexicon
11. Parkinson’s Disease and Alzheimer’s Disease :Neurodegenerative Disorders Due to Brain Antioxidant System Deficiency ?
12. Calpain Hydrolysis of α- and β2-Adaptins Decreases Clathrin-dependent Endocytosis and May Promote Neurodegeneration
13. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression
14. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease
15. Tau, a biological marker of neurodegenerative diseases
16. Alkalizing Drugs Induce Accumulation of Amyloid Precursor Protein By-products in Luminal Vesicles of Multivesicular Bodies
17. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
18. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms
19. Intracellular pH regulates amyloid precursor protein intracellular domain accumulation
20. Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease
21. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology
22. Pin1: A therapeutic target in Alzheimer neurodegeneration
23. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms
24. Pin1 allows for differential Tau dephosphorylation in neuronal cells
25. Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in β-amyloid deposits in the cerebral cortex of vitamin A deprived rats
26. Association of corticobasal degeneration and Huntington's disease: Can Tau aggregates protect Huntingtin toxicity?
27. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism
28. Tau protein as a differential biomarker of tauopathies
29. Biochemistry of Tau in Alzheimerʼs disease and related neurological disorders
30. Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/ parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes
31. Absence of β-Amyloid Deposits After Immunization in Alzheimer Disease With Lewy Body Dementia
32. Treatment of frontotemporal dementia
33. Tau Phosphorylation
34. Contributors
35. General cortical involvement in a late-onset case of Alzheimer disease: A biochemical approach by quantitation of abnormal tau proteins
36. Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in β-amyloid load
37. Effects of Aβ1–42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the τ-protein and on the α7 nicotinic acetylcholine receptor in vitro
38. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases
39. Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated Aβ 42 Accumulation in a Novel Alzheimer Transgenic Model
40. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24
41. In vitro models of age-related neurodegenerative disorders
42. Truncated beta-amyloid peptide species in pre-clinical Alzheimerʼs disease as new targets for the vaccination approach
43. Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis?
44. Stable-Tau Overexpression in Human Neuroblastoma Cells: An Open Door for Explaining Neuronal Death in Tauopathies
45. Pin 1: A Therapeutic Target in Alzheimer Neurodegeneration
46. Neurosteroid Quantification in Human Brain Regions: Comparison between Alzheimer’s and Nondemented Patients
47. Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis
48. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimerʼs disease
49. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities
50. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.